
|Articles|November 30, 2012
Supplements and Featured Publications
- New Approaches to Measuring Value in Oncology Therapy
- Volume 18
- Issue 11 Suppl
Appendix B -- Value of Survival Gains in Chronic Myeloid Leukemia
Advertisement
Articles in this issue
over 13 years ago
eAppendix -- New Approaches to Measuring Value in Oncology Therapyover 13 years ago
Appendix A -- Value of Survival Gains in Chronic Myeloid Leukemiaover 13 years ago
Dynamic Cost-Effectiveness of Oncology Drugsover 13 years ago
Value of Survival Gains in Chronic Myeloid LeukemiaAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss
2
Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year
3
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
4
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
5



